Exact Mass: 412.0606

Exact Mass Matches: 412.0606

Found 10 metabolites which its exact mass value is equals to given mass value 412.0606, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Nitrofenac

2-((2,6-Dichlorophenyl) amino)benzeneacetate-4-hydroxybutylnitric ester

C18H18Cl2N2O5 (412.0593)


   

(3-amino-6-phenyl-4-thiophen-2-ylthieno[2,3-b]pyridin-2-yl)-phenylmethanone

(3-amino-6-phenyl-4-thiophen-2-ylthieno[2,3-b]pyridin-2-yl)-phenylmethanone

C24H16N2OS2 (412.0704)


   

niclosamide piperazine salt

niclosamide piperazine salt

C17H18Cl2N4O4 (412.0705)


   

Desfluoro Bicalutamide

Desfluoro Bicalutamide

C18H15F3N2O4S (412.0705)


   

[4,4,5,5,6,7,7,7-octafluoro-2-hydroxy-6-(trifluoromethyl)heptyl] 2-methylprop-2-enoate

[4,4,5,5,6,7,7,7-octafluoro-2-hydroxy-6-(trifluoromethyl)heptyl] 2-methylprop-2-enoate

C12H11F11O3 (412.0533)


   

(7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanate(2-)

(7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanate(2-)

C16H16N2O9S-2 (412.0576)


   

(E)-N-[N-(5-Methyl-3-phenyl-isoxazole-4-carbonyl)-hydrazinocarbothioyl]-3-thiophen-2-yl-acrylamide

(E)-N-[N-(5-Methyl-3-phenyl-isoxazole-4-carbonyl)-hydrazinocarbothioyl]-3-thiophen-2-yl-acrylamide

C19H16N4O3S2 (412.0664)


   

methyl 8-[(2E)-2-[(6-bromo-1,3-benzodioxol-5-yl)methylidene]hydrazinyl]-8-oxooctanoate

methyl 8-[(2E)-2-[(6-bromo-1,3-benzodioxol-5-yl)methylidene]hydrazinyl]-8-oxooctanoate

C17H21BrN2O5 (412.0634)


   

(7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanate(2-)

(7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanate(2-)

C16H16N2O9S (412.0576)


Dicarboxylate anion of (7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanate acid.

   

A 839977

A 839977

C19H14Cl2N6O (412.0606)


A 839977 is a P2X7 selective antagonist; it blocks BzATP-evoked calcium influx at recombinant human, rat and mouse P2X7 receptors (IC50 values are 20 nM, 42 nM and 150 nM respectively) and reduces inflammatory and neuropathic pain in animal models; the antihyperalgesic effects of P2X7 receptor blockade are mediated by blocking the release of IL-1beta[1].